The Food and Drug Administration has approved the drug Krintafel (tafenoquine) for the treatment of malaria following a Priority Review this past Friday. The drug, developed by GSK Pharmaceuticals and Medicines for Malaria Venture, is a single dose medication designed for people who’ve had malaria before. It prevents the relapse of malaria caused by Plasmodium ...